Journal of Nanomaterials to publish Siva Therapeutics paper on photothermal cancer therapy
Breakout Labs company Siva Therapeutics will have its first peer-reviewed publication in the open-access Journal of Nanomaterials.
The paper describes Siva’s approach to photothermal monotherapy for melanoma. The study, “Photothermal therapy using gold nanorods and near-infrared light in a murine melanoma model increases survival and decreases tumor volume,” demonstrates the capabilities of SivaRod™ monotherapy in the aggressive B16F10 mouse melanoma model. The preprint is available here.
“This work validates the ability of our approach to deliver potent and targeted heat, with minimal collateral damage,” said Len Pagliaro, PhD, CEO of Siva. “We are now focusing on using SivaRod™ therapy as part of combination therapies, and with targeted nanorods.”
